Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000123076 | SCV000166371 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000562046 | SCV000670765 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000562046 | SCV000911286 | likely benign | Hereditary cancer-predisposing syndrome | 2018-03-29 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001255469 | SCV001431884 | likely benign | not specified | 2020-08-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001711209 | SCV001944513 | benign | not provided | 2015-05-08 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149839 | SCV003838388 | likely benign | Breast and/or ovarian cancer | 2021-12-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001711209 | SCV004010653 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | PMS2: BP4, BP7 |
All of Us Research Program, |
RCV003997414 | SCV004844231 | likely benign | Lynch syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing |